Carl Zeiss Meditec AG Financial Statements (AFX.DE)
|
|
|
|
Report date
|
|
|
30.09.2021 |
30.09.2022 |
30.09.2023 |
30.09.2024 |
30.09.2025 |
|
30.09.2025 |
|
Currency
|
|
|
EUR |
EUR |
EUR |
EUR |
EUR |
|
EUR |
|
|
Revenue, € |
? |
|
1 646 785 000 |
1 902 836 000 |
2 089 300 000 |
2 066 127 000 |
2 227 645 000 |
|
2 227 692 000 |
|
Operating Income, € |
|
|
378 667 000 |
406 773 000 |
327 136 000 |
176 351 119 |
256 803 000 |
|
294 978 000 |
|
EBITDA, € |
? |
|
409 212 000 |
482 357 000 |
502 770 000 |
403 061 000 |
346 894 000 |
|
359 762 500 |
|
Net profit, € |
? |
|
236 276 000 |
293 909 000 |
290 396 000 |
178 726 000 |
141 210 000 |
|
141 216 000 |
|
|
OCF, € |
? |
|
362 663 000 |
188 199 000 |
250 861 000 |
247 319 000 |
209 858 000 |
|
183 558 000 |
|
CAPEX, € |
? |
|
66 101 000 |
81 971 000 |
113 861 000 |
152 204 000 |
39 394 000 |
|
39 394 000 |
|
FCF, € |
? |
|
296 562 000 |
106 228 000 |
137 000 000 |
95 115 000 |
170 464 000 |
|
144 164 000 |
|
Dividend payout, €
|
|
|
44 720 000 |
80 497 000 |
98 385 000 |
98 204 000 |
52 522 000 |
|
52 522 000 |
|
|
Ordinary share dividend yield, %
|
|
|
0.00% |
0.00% |
|
0.00% |
0.00% |
|
0.00% |
|
Dividend payout ratio, %
|
|
|
18.9% |
27.4% |
33.9% |
54.9% |
37.2% |
|
37.2% |
|
|
OPEX, € |
|
|
588 546 000 |
720 825 000 |
878 629 000 |
912 278 881 |
918 394 000 |
|
1 168 469 000 |
|
Cost of production, € |
|
|
679 572 000 |
775 238 000 |
883 535 000 |
977 497 000 |
1 052 448 000 |
|
1 312 499 000 |
|
R&D, € |
|
|
232 066 000 |
291 365 000 |
349 278 000 |
343 089 000 |
326 275 000 |
|
407 717 000 |
|
Interest expenses, € |
|
|
8 578 000 |
9 099 000 |
15 250 000 |
14 579 000 |
26 624 000 |
|
39 928 000 |
|
|
Assets, € |
|
|
2 395 968 000 |
2 822 817 000 |
3 032 924 000 |
3 393 200 000 |
3 459 437 000 |
|
3 459 437 000 |
|
Net Assets, € |
? |
|
1 659 327 000 |
2 015 100 000 |
2 159 453 000 |
2 041 697 000 |
2 116 506 000 |
|
2 116 506 000 |
|
Debt, € |
|
|
217 159 000 |
127 903 000 |
297 724 000 |
612 725 000 |
607 366 000 |
|
607 366 000 |
|
Cash, € |
|
|
7 439 000 |
7 729 000 |
10 601 000 |
20 285 000 |
27 267 000 |
|
27 267 000 |
|
Net debt, € |
|
|
209 720 000 |
120 174 000 |
287 123 000 |
592 440 000 |
580 099 000 |
|
580 099 000 |
|
|
Ordinary share price, rub |
|
|
166.1 |
107.5 |
|
71.2 |
42.2 |
|
25.9 |
|
Number of ordinary shares, mln |
|
|
89 440 570 |
89 440 570 |
89 440 570 |
88 851 084 |
87 536 079 |
|
87 536 079 |
|
|
Market cap, € |
|
|
14 851 606 649 |
9 610 389 247 |
0.00 |
6 321 754 627 |
3 690 521 091 |
|
2 270 685 889 |
|
EV, € |
? |
|
15 061 326 649 |
9 730 563 247 |
287 123 000 |
6 914 194 627 |
4 270 620 091 |
|
2 850 784 889 |
|
Book value, € |
|
|
1 176 915 000 |
1 345 025 000 |
1 484 181 000 |
352 342 000 |
483 893 000 |
|
483 893 000 |
|
|
EPS, rub |
? |
|
2.64 |
3.29 |
3.25 |
2.01 |
1.61 |
|
1.61 |
|
FCF/share, rub |
|
|
3.32 |
1.19 |
1.53 |
1.07 |
1.95 |
|
1.65 |
|
BV/share, rub |
|
|
13.2 |
15.0 |
16.6 |
3.97 |
5.53 |
|
5.53 |
|
|
EBITDA margin, % |
? |
|
24.8% |
25.3% |
24.1% |
19.5% |
15.6% |
|
16.1% |
|
Net margin, % |
? |
|
14.3% |
15.4% |
13.9% |
8.65% |
6.34% |
|
6.34% |
|
FCF yield, % |
? |
|
2.00% |
1.11% |
|
1.50% |
4.62% |
|
6.35% |
|
ROE, % |
? |
|
14.2% |
14.6% |
13.4% |
8.75% |
6.67% |
|
6.67% |
|
ROA, % |
? |
|
9.86% |
10.4% |
9.57% |
5.27% |
4.08% |
|
4.08% |
|
|
P/E |
? |
|
62.9 |
32.7 |
0.00 |
35.4 |
26.1 |
|
16.1 |
|
P/FCF |
|
|
50.1 |
90.5 |
0.00 |
66.5 |
21.6 |
|
15.8 |
|
P/S |
? |
|
9.02 |
5.05 |
0.00 |
3.06 |
1.66 |
|
1.02 |
|
P/BV |
? |
|
12.6 |
7.15 |
0.00 |
17.9 |
7.63 |
|
4.69 |
|
EV/EBITDA |
? |
|
36.8 |
20.2 |
0.57 |
17.2 |
12.3 |
|
7.92 |
|
Debt/EBITDA |
|
|
0.51 |
0.25 |
0.57 |
1.47 |
1.67 |
|
1.61 |
|
|
R&D/CAPEX, % |
|
|
351.1% |
355.4% |
306.8% |
225.4% |
828.2% |
|
1 035% |
|
|
CAPEX/Revenue, % |
|
|
4.01% |
4.31% |
5.45% |
7.37% |
1.77% |
|
1.77% |
|
| Carl Zeiss Meditec AG shareholders |
